First Time Loading...

Denali Therapeutics Inc
NASDAQ:DNLI

Watchlist Manager
Denali Therapeutics Inc Logo
Denali Therapeutics Inc
NASDAQ:DNLI
Watchlist
Price: 18.9 USD -1.61% Market Closed
Updated: May 29, 2024

Denali Therapeutics Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Denali Therapeutics Inc
Other Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Denali Therapeutics Inc
NASDAQ:DNLI
Other Liabilities
$43m
CAGR 3-Years
-52%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Liabilities
$32.8B
CAGR 3-Years
7%
CAGR 5-Years
18%
CAGR 10-Years
26%
Gilead Sciences Inc
NASDAQ:GILD
Other Liabilities
$3.4B
CAGR 3-Years
-20%
CAGR 5-Years
-14%
CAGR 10-Years
24%
Amgen Inc
NASDAQ:AMGN
Other Liabilities
$6.3B
CAGR 3-Years
-12%
CAGR 5-Years
-9%
CAGR 10-Years
0%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Liabilities
$1.2B
CAGR 3-Years
23%
CAGR 5-Years
51%
CAGR 10-Years
33%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Liabilities
$1.1B
CAGR 3-Years
22%
CAGR 5-Years
-2%
CAGR 10-Years
18%

See Also

What is Denali Therapeutics Inc's Other Liabilities?
Other Liabilities
43m USD

Based on the financial report for Mar 31, 2024, Denali Therapeutics Inc's Other Liabilities amounts to 43m USD.

What is Denali Therapeutics Inc's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
-18%

Over the last year, the Other Liabilities growth was -17%. The average annual Other Liabilities growth rates for Denali Therapeutics Inc have been -52% over the past three years , -18% over the past five years .